Pharmacology 23 - Adverse Drug Reactions Flashcards

1
Q

Define adverse drug event

A

Preventible or unpredicted medication event with harm to patient

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe the epidemiology of adverse drug reactions

A
  • Substantial morbidity and mortality
  • Estimates of incidence vary with study methods, population, and ADR definition
  • 4th to 6th leading cause of death among hospitalized patients
  • 6.7% incidence of serious ADRs
  • 0.3% to 7% of all hospital admissions
    annual costs in the billions ($120 billion in US)
  • 30% to 60% are preventable
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How are adverse drug reactions classified?

A
  • Onset (how quickly they happen)
  • Severity (how bad they are)
  • Type
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

List the different onsets of ADRs

A
  • Acute (within 1 hour eg. anaphylaxis)
  • Subacute (1 to 24 hours)
  • Latent (more than 2 days)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

List the different severities of ADRs

A
  • Mild (requires no change in therapy)
  • Moderate (requires change in therapy, additional treatment and hospitalisation)
  • Severe (disabling or life-threatening)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

List characteristics of severe adverse drug reactions

A
  • Results in death
  • Life-threatening
  • Requires or prolongs hospitalisation
  • Causes disability
  • Causes congenital anomalies
  • Requires intervention to prevent permanent injury
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

List characteristics of type A adverse drug reactions

A

60-70% of adverse reactions

  • Extension of pharmacologic effect
  • Usually predictable and dose dependent
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

List examples of type A adverse drug reactions

A
  • Atenolol and heart block (or bradycardia)
  • Anticholinergics and dry mouth, constipation or visual disturbances
  • NSAIDS and peptic ulcer
  • Digoxin has a linear relationship between adverse reaction and dose
  • Paracetamol is harmless at a wide dose range, but beyond a certain dose there is a sharp increase in toxicity (resulting in liver damage and even need for transplant)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

List characteristics of type B adverse drug reactions

A
  • Idiosyncratic (will happen in some people but not others) or immunologic reactions
  • Includes allergy and “pseudoallergy”
  • Rare (even very rare) and unpredictable
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

List examples of type B adverse drug reactions

A
  • Chloramphenicol and aplastic anemia (total bone marrow failure, tends to not be survived)
  • ACE inhibitors and angioedema (swelling of the lips and lung, rarely heart failure non immunological form of anaphylaxis)
  • Herceptin and cardiac toxicity (totally unexpected)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

List characteristics of type C adverse drug reactions

A
  • Associated with long-term use

- Involves dose accumulation over a period of time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

List examples of type C adverse drug reactions

A
  • Methotrexate (immunosuppressant/ cancer use) and liver fibrosis
  • Antimalarials and ocular toxicity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

List characteristics of type D drug reactions

A

Delayed effects, sometimes dose independent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

List examples of type D drug reactions

A
  • Carcinogenicity (e.g. immunosuppressant)

- Teratogenicity (e.g. thalidomide)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

List characteristics of type E adverse drug reactions and give examples

A
  • Withdrawal reactions (opiates, benzodiazepines, corticosteroids)
  • Rebound reactions where the drug is stopped and people become worse than before they started it (clonidine, beta blockers, corticosteroids)
  • Adaptive reactions *(neuroleptics)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

List the types of adverse drug reactions

A
  • Type A (augmented pharmacological effect)
  • Type B (bizarre)
  • Type C (chronic)
  • Type D (delayed)
  • Type E (end of treatment)
17
Q

List types of allergic reactions and give examples

A
  • Type 1 - immediate anaphlactic (IgE mediated - eg. anaphylaxis and penicillin)
  • Type II - cytotoxic antibody (IgM and IgG mediated, eg. methyldopa and haemolytic anaemia)
  • Type III - serum stickiness with antigen-antibody complex cormation (IgG, IGM medaited, eg. procainamide induced lupus)
  • Type IV - delayed hypersensitivity (t cell eg. contact dermatitis)
18
Q

Give examples of pseudoalleragies

A
  • Aspirin/ NSAIDS causing bronchospasm (care with asthmatics)
  • ACE inhibitors causing cough (15-20%)/ angioedema (1%)
19
Q

List the common causes of ADRs

A
  • Antibiotics
  • Antineoplastics *
  • Anticoagulants
  • Cardiovascular drugs *
  • Hypoglycaemics
  • Antihypertensives
  • NSAID/ analgesics *
  • CNS drugs *
  • = cause 2/3rds of fatal ADRs
20
Q

How are ADRs detected?

A
  • Via subjective reports, eg. patient complaints
  • Objective report (direct observation of events, with abnormal findings on physical examination, lab tests and diagnostic procedures)
21
Q

What is the yellow card screen?

A
  • Introduced post thalidomide
  • Used by HCPs and members of the public
  • For black triangle drugs, which are newly licensed (2 years), any suspected adverse reaction is reported
  • For established drugs, only serious adverse reactions are reported
  • Used as it is unlikely rare events will be detected before the drug is marketed
  • Prescribers informed once ADR confirmed and frequency is estimated
22
Q

Why is incidence of drug-drug interactions difficult to determine?

A
  • Data for drug-related hospital admissions do not separate out drug interactions, focus on ADRs
  • Lack of availability of comprehensive databases
  • Difficulty in assessing - OTC and herbal drug therapy use
  • Difficulty in determining contribution of drug interaction in complicated patients
  • Sometimes principal cause of ADRs with specific drugs eg statins
23
Q

List the three types of drug interactions

A
  • Pharmacodynamic (drugs effect in the body)
  • Pharmacokinetic (body effects on the drug, ADME)
  • Pharmaceutical (drugs interacting outside the body, mostly IV infusions)
24
Q

Describe pharmacodynamic drug interactions

A
  • Additive (similar affects by different mechanisms), synergistic (one drug potentiates another drug to increase its function), or antagonistic effects from co-administration of two or more drugs
  • Synergistic actions of antibiotics
  • Overlapping toxicities - ethanol and benzodiazepines
  • Antagonistic effects - anticholinergic medications (amitriptyline and acetylcholinesterase inhibitors)
25
Q

Describe pharmacokinetic drug interations

A
  • Alteration in absorption (chelation)
  • Protein binding effects
  • Changes in drug metabolism
  • Alteration in elimination
26
Q

Describe chelation

A
  • Alteration of absorption
  • Irreversible binding of drugs in the GI tract, altering absorption making active drugs insoluble
  • Tetracyclines, quinolone antibiotics - ferrous sulfate (Fe+2), antacids (Al+3, Ca+2, Mg+2), dairy products (Ca+2)
27
Q

Describe protein binding interactions of drugs

A
  • Competition between drugs for protein or tissue binding sites
  • Increase in free (unbound) concentration may lead to enhanced pharmacological effect
  • Many interactions previously thought to be protein binding interactions were found to be primarily metabolism interactions
  • Protein binding interactions are not usually clinically significant but a few are (mostly with warfarin)
28
Q

Describe drug metabolism interactions

A
  • Drug metabolism inhibited or enhanced by coadministration of other drugs
  • CYP 450 system has been the most extensively studied (CYP3A4, CYP2D6, CYP1A2, CYP2B6, CYP2C9, CYP2C19 and others).
  • Phase 2 metabolic interactions
    (glucuronidation, etc.) can occur
29
Q

Describe metabolism of CYP450 substrates

A
  • Metabolism by a single isozyme (predominantly - few examples of clnically used drugs)
  • Metabolism by multiple isozymes (most drugs - therefore, isozymes will take over metabolism when one isozyme becomes inhibited)
30
Q

Give an example of drugs metabolised by multiple isozymes

A

Imipramine: CYP2D6, CYP1A2, CYP3A4, CYP2C19

31
Q

List CYP450 inhibitors

A
  • Cimetidine
  • Erythromycin and related antibiotics
  • Ketoconazole etc
  • Ciprofloxacin and related antibiotics
  • Ritonavir and other HIV drugs
  • Fluoxetine and other - SSRIs
  • Grapefruit juice
32
Q

List CYP450 inducers

A
  • Rifampicin
  • Carbamazepine
  • (Phenobarbitone)
  • (Phenytoin)
  • St John’s wort - mood altering drug (hypericin)
33
Q

Compare inhibition and iduction

A
  • Inhibition is very rapid

- Induction takes hours/ days

34
Q

Describe drug elimination interactions. Give examples

A
  • Almost always occur in the renal tubule
  • Probenecid and penicilin (good - increased plasma penicillin)
  • Lithium and thiazides (bad - due to increased sodium excretion at the expense of lithium, lithium is retained to toxic levels)
35
Q

List deliberate drug interactions

A
  • Levodopa and carbidopa (increase efficacy of levodopa in CNS)
  • ACE inhibitors and thiazides (anti-hypertensives)
  • Penicillins and gentamicin (staphylococcal infections)
  • Salbutamol and ipratropium (beta agonist + anticholinergic)
36
Q

Describe adverse drug reaction to clonidine

A
  • Used in hypertension (a2 receptor agonist)
  • During use, blood pressure is decreased
  • After use, blood pressure increases to a point where there is large risk of stroke
37
Q

What are pseudoallergies?

A
  • Not allergies
  • Not associated with immune response
  • Pharmacologically mediated
38
Q

Describe relationship between increased medications and ADRs

A

Positive correlation

39
Q

Describe the three drug metabolism and elimination pathways

A
  • Some drugs excreted unchanged by the kidney
  • Some phase 1 metabolism (oxidation most common, also reduction or hydrolysys. Liver/kidney excretion follows)
  • Can be phase 2 metabolism (conjugation via glucorinidation/ sulphation/ acetylation. Excreted from the kidney in water soluble form)